A Controlling Shareholder Pushed a Related-Party Deal Past Its Own Committee

The situation

Rabia's minority stake in the construction company was worth, on the most recent valuation the shareholders had agreed to, somewhere around three million dollars. That number sat at the centre of everything that followed, because it was the figure a proposed related-party transaction threatened to shrink, and it was the figure Rabia had in mind when she finally called our office, several weeks after she had signed a document she said she did not fully understand.

Rabia was a specialist physician who had incorporated her practice years earlier and, on her accountant's advice, used the professional corporation to hold a minority interest in a construction company built and controlled by Cristina, a longtime family friend. The company had grown well past thirty million dollars in annual revenue over a decade, largely on Cristina's management, and Rabia's role had always been passive: attend the annual meeting, review the financials her accountant summarized for her, collect the occasional dividend. She had never expected to need a lawyer for it.

That changed when Cristina proposed transferring a substantial block of the company's equipment and a long-term contract to a separate company she owned personally, at a price the existing shareholders' agreement required a special committee of independent, non-conflicted directors to review before it could proceed. Paulo, another minority shareholder and the owner of his own construction business, sat on that committee alongside one other independent director. The committee reviewed the proposed transfer and recommended against it, concluding the price undervalued what was being moved.

Cristina, as the majority and controlling shareholder, held enough votes to approve the transaction over the committee's objection, and did. Somewhere in the weeks before that vote, Rabia had signed a consent and waiver document Cristina's lawyer had circulated to all shareholders, described to her informally as routine paperwork tied to the review process. By the time Rabia understood what she had actually signed, the deal had already closed.

What made Rabia's position particularly uncomfortable was the relationship underneath the paperwork. She and Cristina had known each other for close to twenty years; the investment in the construction company had grown out of that friendship rather than any arm's length dealing, and Rabia had always treated the shareholding the way she treated a retirement account, something she trusted someone else to manage well on her behalf. She had no experience reviewing corporate consent documents and had never needed independent counsel of her own before, because nothing had ever required it. That trust was precisely what the circulated waiver traded on, whether or not anyone intended it that way.

What the review found

Once Rabia retained us, the first step was reconstructing exactly what had happened and what she had agreed to, because her own account of events was incomplete and the document she had signed was doing more legal work than she realized. We requested and reviewed the full record of the special committee's process: its terms of reference, the valuation materials it had considered, its written recommendation, and the minutes of the shareholder vote that followed.

The committee's own analysis was thorough and, on its face, correct. It had retained an independent valuator, reviewed the proposed transfer price against comparable equipment and contract values, and concluded in writing that the price Cristina's related company was offering sat meaningfully below fair value, likely by an amount in the mid six figures. The committee's recommendation against the transaction was clearly reasoned and properly documented, which mattered enormously for what came next, because it meant the process the shareholders' agreement required had been followed correctly even though the outcome was not.

The document Rabia had signed was the more difficult finding. It was a consent that, among other things, waived her right to challenge the transaction's fairness and confirmed she had received and reviewed the committee's report, which she had not, in any meaningful sense. Cristina's lawyer had circulated it to all minority shareholders as a formality; Rabia, trusting a long relationship and not reading the document closely, had signed it without asking what it did. That waiver significantly narrowed what could realistically be pursued, because it went directly to the argument that would otherwise have been the strongest one available to her.

What the review ultimately found was not a case of concealment. The committee process had functioned as intended, its finding had been ignored by a shareholder who was legally entitled to override it, and the strongest response available to Rabia had been substantially weakened before she ever sought advice. The question our review answered was not whether the deal had been done properly in principle, but how much room remained to respond given what had already been signed.

We also looked closely at the timeline between the committee's written recommendation and the shareholder vote that overrode it, because a very short gap can sometimes suggest a controlling shareholder never seriously considered the committee's findings at all. Here the gap was several weeks, and the record showed Cristina's counsel had prepared a written response addressing the valuation gap, arguing the equipment carried maintenance liabilities the committee's valuator had not fully priced in. That response was debatable, but it was not nothing, and it meant the override could not be characterized as reckless or procedurally hollow, only as a legally available choice Cristina was entitled to make once the process had run its course.

What we did

We started by confirming, carefully, what the signed waiver actually foreclosed and what it did not. It barred a direct challenge to the transaction's fairness, but it did not address Cristina's separate, ongoing obligations to the company as a director, including her duty to act in the company's interest even when a related-party deal benefited her personally. That distinction became the basis for everything that followed, because it meant the file was not closed, even if the specific transaction could not be reopened.

We then reviewed the company's financial position following the transfer to establish, in concrete terms, what it had cost the company and, by extension, the value of Rabia's shares. Using the committee's own valuation work as a starting point, we prepared an assessment showing the transaction had reduced enterprise value by an amount that translated to a meaningful decline in what Rabia's minority stake was worth.

Rather than pursue a claim likely to fail on the waiver, we opened a direct negotiation with Cristina's counsel, framed around her ongoing duties to the company rather than the closed transaction, and proposed a compensating payment to the minority shareholders reflecting the value the committee had identified as underpaid. We coordinated with Paulo, whose own minority position gave him a shared interest in the outcome, so the two shareholders were negotiating from a unified position rather than separately. We also arranged for a revised shareholders' agreement provision going forward, requiring that any future related-party consent be presented to minority shareholders with independent legal advice made available before signature, closing the gap that had let the earlier waiver through unexamined. Finally, we documented the full record for Rabia so that if Cristina proposed a similar transaction again, the history and the new consent protections would already be on file.

Throughout the negotiation, we kept Rabia's practice and her professional obligations separate from the shareholder dispute, since her professional corporation's involvement in the construction company had no bearing on her medical practice and there was no reason for the two to become entangled in the other side's correspondence. We also declined an early settlement offer from Cristina's counsel that would have required Rabia to sign a further broad release in exchange for a modest payment, on the basis that it repeated the same pattern that had caused the problem in the first place, and pushed instead for the narrower, better-documented compensation structure that eventually closed the file.

The outcome

The underlying transaction stood. Cristina's related company kept the equipment and the contract at the price the committee had found undervalued, and no court process was pursued to unwind it, largely because the signed waiver made that path unlikely to succeed and the cost of trying was not proportionate to what remained achievable. That is the part of the file Rabia did not get to change, and it needs to be stated plainly rather than softened.

What the negotiation did produce was a compensating payment to Rabia and Paulo, paid out of company funds over a defined schedule, calculated against the committee's own valuation shortfall figure and amounting to a meaningful fraction of what the undervaluation had cost them. It did not restore the full value the committee had identified, but it recovered a portion that would not have come at all without pressing the point using Cristina's ongoing fiduciary obligations rather than the transaction itself.

The revised consent protocol was the more durable result. Going forward, any related-party transaction requiring shareholder consent now comes with a requirement that independent legal advice be made available before any waiver is signed, a safeguard built directly out of what went wrong here. Rabia's minority stake is smaller in value than it was before this transaction, and she has said plainly that trust in the relationship with Cristina has not fully recovered. The file closed with the damage limited rather than reversed, which is what acting properly, after the fact, was able to achieve.

Rabia has since retained us to review any future consent request from the company before she signs it, a small procedural change that costs her little and closes the exact gap that caused this file to begin with. She has said she regards the outcome as a genuine, if incomplete, recovery rather than a defeat, given how narrow the path back had become by the time she first called.

What you can learn from this